Savara Inc (SVRA)
Healthcare
Biotechnology
5.50 $
-1.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Savara Inc (SVRA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -33 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -10 | -13 | -16 | -21 | -22 | -23 | -23 | -27 | -26 | -23 | -25 | -33 | -107 | |
| 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | -0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.1 | 0.2 | |
| 1.0 | 1.0 | 1.4 | 2.3 | 2.2 | 2.4 | 3.0 | 3.0 | 2.7 | 3.4 | 5.4 | 11 | 22 | |
| 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.1 | 3.8 | 0.7 | -1.3 | -1.6 | 0.7 | 4.1 | -3.1 | 2.1 | 3.8 | 2.2 | -6.1 | 1.9 | |
| 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | |
| -1.0 | -57 | 6.6 | 11 | 30 | -98 | 18 | 29 | 24 | 21 | -94 | 39 | -9.0 | |
| 0.0 | -0.2 | -1.0 | 0.0 | 0.0 | -0.1 | -0.9 | -0.2 | -0.1 | 0.0 | -4.8 | -0.2 | -5.2 | |
| – | – | – | – | – | 0.0 | – | 2.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.1 | 75 | 7.9 | 0.0 | 0.1 | 118 | -0.8 | 2.3 | 0.0 | 0.0 | 136 | -0.2 | 135 | |
| -11 | 4.9 | -1.1 | -9.8 | 7.1 | -2.4 | -6.3 | 4.4 | -2.1 | -1.2 | 17 | 5.6 | 19 | |
| -10 | -13 | -16 | -21 | -23 | -23 | -23 | -27 | -26 | -23 | -25 | -33 | -107 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.